NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding NextCure, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 51 | 52 | +1 |
| Shares | 14.5M | 15.2M | +786.7K (+5.4%) |
| Value | $67.9M | $41.8M | −$26.2M (−38.5%) |
New holders (5)
Institutions that held NextCure, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| FNY Investment Advisers, LLC | 48,000 | $132.0K | 0.09% |
| Group One Trading, L.P. | 30,093 | $83.0K | 0.00% |
| Privium Fund Management (UK) Ltd | 24,400 | $67.0K | 0.09% |
| Cubist Systematic Strategies, LLC | 12,163 | $33.0K | 0.00% |
| China Universal Asset Management Co., Ltd. | 260 | $1.00K | 0.00% |
Sold out (4)
Institutions that held NextCure, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Assenagon Asset Management S.A. | 108,630 | $511.0K |
| Ikarian Capital, LLC | 71,435 | $336.0K |
| XTX Topco Ltd | 21,929 | $103.0K |
| Quantbot Technologies LP | 2,100 | $9.00K |